Advertisement

IASLC World Conference on Lung Cancer

At-Home Prehab May Improve Outcomes Following Lung Cancer Surgery

February 2nd 2021

Recent study results demonstrated that an at-home prehabilitation program may improve surgical outcomes in patients with lung cancer.

COVID-19 Pandemic May Negatively Impact Patients’ Ability to Access Care for Lung Cancer

February 2nd 2021

A survey conducted by the LUNGevity Foundation determined that 96% of patients with lung cancer felt that they were concerned about the COVID-19 pandemic affecting their treatment.

Patients with Lung Cancer Have Experienced More Psychological Distress During COVID-19 Than Those With Other Cancer Diagnoses

February 2nd 2021

New study results demonstrate that patients with lung cancer have experienced more worries and general distress during the COVID-19 pandemic compared to other patients with cancer.

Decreased Funding Due to the COVID-19 Pandemic Has Negative Impact on Lung Cancer Patient Advocacy and Support Organizations

February 1st 2021

Despite offering an increased number of services to patients, the decrease in funding as a result of the pandemic has put a strain on patient advocacy and support organizations around the world, leaving many, particularly those that specialize in the support of patients with lung cancer, in urgent need of financial support to continue to meet the increased need.

Long-Term Follow-Up Shows Keytruda Continues to Improve Survival in Patients With PD-L1–Positive Advanced NSCLC

February 1st 2021

Keytruda monotherapy continued to significantly improve overall and progression-free survival in patients with previously treated, PD-L1–positive advanced non-small cell lung cancer.

Onivyde Shows Promise in Patients with Small Cell Lung Cancer Who Become Resistant to Chemotherapy

January 31st 2021

Onivyde may offer patients with small cell lung cancer whose disease has progressed after initial chemotherapy a new treatment option, according to updated study results.

Immunotherapy May Be More Beneficial in Treating Small Cell Lung Cancer

January 30th 2021

Treatment with immuno-oncology therapies induces better responses in younger patients with small cell lung cancer, compared to older patients.

Potential New Treatment Option Shows Promise in Advanced Small Cell Lung Cancer When Combined with Single Agent Chemotherapy

January 29th 2021

Though there are currently few approved treatments for advanced, pre-treated small cell lung cancer (SCLC), this patient population may have a safe and effective new option in apatinib, according to updated data from a prospective phase 2 study.

Patients With Lung Cancer May Need More Support, Education When Making Treatment Decisions

January 29th 2021

In a survey conducted by the Cancer Support Community, 33% of patients with lung cancer reported they were somewhat or not at all involved in the decision-making process, and 66% were not as knowledgeable about their treatment options as needed to make this decision.

Advertisement
Advertisement